NovaBridge Biosciences officer buys 230K shares
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Mark Arnold Hagler, NovaBridge Biosciences’ Chief Commercial Officer, purchased 46,000 ordinary shares on November 17, 2026, at a reported $0.3430 per share. On November 18, he purchased 184,000 ordinary shares at a reported $0.3810 per share. Footnotes associate the purchases with 20,000 and 80,000 ADSs, respectively; each 10 ADSs represent 23 ordinary shares. The cited ADS prices were $0.79 and a weighted average of $0.8758, with the November 18 ADS purchases ranging from $0.84 to $0.90. No Rule 10b5-1 plan is reported.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Purchase | Ordinary Shares F1, F4, F5 | 184,000 | $0.381 | $70K |
| Purchase | Ordinary Shares F1, F2, F3 | 46,000 | $0.343 | $16K |
Footnotes (5)
- F1. The Ordinary Shares may be represented by American Depositary Shares ("ADS"). Each 10 ADSs represent 23 Ordinary Shares of the Issuer.
- F2. Reported securities are represented by 20,000 ADSs.
- F3. The price reported in Column 4 represents the converted sales price of the ADSs of $0.79.
- F4. Reported securities are represented by 80,000 ADSs.
- F5. The price reported in Column 4 represents the converted weighted average price per ADS of $0.8758. These ADSs were purchased in multiple transactions at prices ranging from $0.84 to $0.90 per ADS, inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.
Key Figures
Key Terms
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
AI-generated analysis. How Rhea-AI works. Not financial advice.